Frankfurt - Delayed Quote EUR

Fresenius SE & Co. KGaA (FREA.F)

Compare
8.55
+0.05
+(0.59%)
As of 8:16:55 AM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
22,811,000.00
22,299,000.00
21,532,000.00
37,520,000.00
36,277,000.00
Cost of Revenue
17,480,000.00
17,241,000.00
16,129,000.00
27,209,000.00
25,961,000.00
Gross Profit
5,331,000.00
5,058,000.00
5,403,000.00
10,311,000.00
10,316,000.00
Operating Expense
3,945,000.00
3,915,000.00
3,591,000.00
6,153,000.00
5,931,000.00
Operating Income
1,386,000.00
1,143,000.00
1,812,000.00
4,158,000.00
4,385,000.00
Net Non Operating Interest Income Expense
-474,000.00
-416,000.00
-215,000.00
-506,000.00
-659,000.00
Pretax Income
910,000.00
715,000.00
1,597,000.00
3,652,000.00
3,726,000.00
Tax Provision
552,000.00
477,000.00
375,000.00
833,000.00
903,000.00
Net Income Common Stockholders
-383,000.00
-594,000.00
1,372,000.00
1,818,000.00
1,707,000.00
Diluted NI Available to Com Stockholders
-383,000.00
-594,000.00
1,372,000.00
1,818,000.00
1,707,000.00
Basic EPS
-0.17
-0.26
0.61
0.81
0.76
Diluted EPS
-0.17
-0.26
0.61
0.81
0.76
Basic Average Shares
2,252,949.11
2,252,949.11
2,245,057.22
2,232,247.51
2,233,898.73
Diluted Average Shares
2,252,949.11
2,252,949.11
2,245,057.22
2,232,625.30
2,235,069.28
Total Operating Income as Reported
1,386,000.00
1,143,000.00
1,812,000.00
4,158,000.00
4,385,000.00
Total Expenses
21,425,000.00
21,156,000.00
19,720,000.00
33,362,000.00
31,892,000.00
Net Income from Continuing & Discontinued Operation
-383,000.00
-594,000.00
1,372,000.00
1,818,000.00
1,707,000.00
Normalized Income
512,000.00
1,344,000.00
477,000.00
1,818,000.00
1,707,000.00
Interest Income
--
118,000.00
130,000.00
124,000.00
93,000.00
Interest Expense
--
534,000.00
345,000.00
630,000.00
752,000.00
Net Interest Income
-474,000.00
-416,000.00
-215,000.00
-506,000.00
-659,000.00
EBIT
1,492,000.00
1,249,000.00
1,942,000.00
4,282,000.00
4,478,000.00
EBITDA
3,041,000.00
2,727,000.00
3,099,000.00
6,949,000.00
7,193,000.00
Reconciled Cost of Revenue
17,480,000.00
17,241,000.00
16,129,000.00
27,209,000.00
25,961,000.00
Reconciled Depreciation
1,549,000.00
1,478,000.00
1,157,000.00
2,667,000.00
2,715,000.00
Net Income from Continuing Operation Net Minority Interest
512,000.00
1,344,000.00
477,000.00
1,818,000.00
1,707,000.00
Total Unusual Items Excluding Goodwill
--
--
--
--
31,000.00
Total Unusual Items
--
--
--
--
31,000.00
Normalized EBITDA
3,041,000.00
2,727,000.00
3,099,000.00
6,949,000.00
7,193,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 2/10/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MEDICAB.MX Médica Sur, S.A.B. de C.V.
33.80
+1.84%
 
LIK.DE LIMES Schlosskliniken AG
336.00
0.00%
 
DANE.TA Danel (Adir Yeoshua) Ltd
42,840.00
-0.81%
 
MCOV-B.ST Medicover AB (publ)
197.20
+2.28%
 
6H90.MU Healwell AI Inc
1.1600
+6.91%
 
INNV InnovAge Holding Corp.
3.6900
+1.93%
 
LAS-CONDES.SN Clínica Las Condes S.A.
12,042.00
+0.48%
 
LWSCF Sienna Senior Living Inc.
10.22
+0.39%
 
EMEIS.PA EMEIS
5.27
-1.16%
 
PHA.V Premier Health of America Inc.
0.1450
0.00%